What Researchers Did
Researchers conducted a meta-analysis of nine randomized clinical trials involving 526 patients to assess the efficacy and safety of hyperbaric oxygen therapy (HBOT) for diabetic foot ulcers.
What They Found
No significant differences were found between hyperbaric oxygen therapy (HBOT) and standard therapy for healed ulcers (risk ratio [RR] = 2.22), minor amputations (RR = 0.95), major amputations (RR = 0.47), or adverse events (RR = 1.00). However, HBOT was associated with a greater reduction in ulcer wound area compared to standard therapy (standard mean difference = 1.12; P = 0.04).
What This Means for Canadian Patients
The findings suggest that HBOT may help reduce the size of diabetic foot ulcers, but it does not appear to improve healing rates or reduce the need for amputations compared to standard care. Patients with diabetic foot ulcers should discuss all treatment options with their healthcare providers, considering that HBOT's benefits might be limited to wound area reduction.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
A significant limitation of this meta-analysis is the high heterogeneity observed across the included studies for most outcomes.